• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- NEWS BRIEFS October 5, 2023

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/all-news

Enhanced IPC measures at cancer center linked to reduced infections during COVID



News brief

Today at 1:47 p.m.
Chris Dall, MA
Topics

Healthcare-Associated Infections

COVID-19

Antimicrobial Stewardship

Robust infection prevention and control (IPC) measures at a comprehensive cancer center during the COVID-19 pandemic were associated with significant decreases in healthcare-associated infections (HAIs), researchers reported today in the American Journal of Infection Control.

To evaluate the impact of IPC practices at the University of Texas MD Anderson Cancer Center during the pandemic, researchers analyzed the monthly incidence rate (IR) of HAIs from September 2016 through March 2022, a period that covered 42 months before and 25 months after the start of the pandemic. Over that period, the hospital cared for more than 1,800 COVID-19 patients.

Stricter IPC measures implemented during the pandemic included increased use of personal protective equipment, enhanced contact precautions, and emphasis on hand hygiene. Among the HAIs analyzed were laboratory-identified Clostridioides difficile infection (Li-CDI), infections caused by multidrug-resistant organisms (MDROs), nosocomial (hospital-acquired) respiratory viral infections (RVIs), and device-related infections.

Overall, the researchers observed a significant decrease in the IR of Li-CDI, central line-associated bloodstream infections, and all nosocomial RVIs combined during the pandemic. Declines were also observed in the IR of infections caused by individual viruses, including flu and respiratory syncytial virus. The IR of catheter-associated urinary tract infections, ventilator-associated events, and MDROs did not significantly change between the two periods.

Higher MDRO incidence in COVID wards


The decrease in HAIs at MD Anderson runs counter to the experience in many US healthcare settings, which saw HAIs rise during the pandemic.

However, the study did find that the IR of MDROs in the COVID-19 wards was five times higher than in other inpatient wards. The study authors say that finding matched data from other hospitals in the United States and around the world showing increases in MDRO HAIs during the pandemic, particularly among patients admitted with COVID-19.

The authors also note that the impact of specific IPC measures (such as universal masking, face shields, and hand hygiene) remains unclear.

"Therefore, whether these enhanced measures, such as masking at all times as part of patient care, are recommended during the upcoming respiratory viral seasons still needs to be determined in future studies," they concluded.
 
Back
Top Bottom